CLR profiling revealed some discrepancies and opposite regulation for a specific CLR between blood and tumor (Clec-9α on cDC1s) or between DC subsets (Clec-12α and CD206 on circulating cDC2s and cDC1s). Here, DCLK3 is linked to neoplasm.